Related Experiment Video
Updated: Jul 29, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Treating fibromyalgia with a brief interdisciplinary program: initial outcomes and predictors of response
L M Worrel1, L E Krahn, C D Sletten
1Mayo Medical School, Mayo Clinic, Rochester, Minn 55905, USA.
A brief fibromyalgia treatment program effectively reduced symptoms. Patients with higher initial fibromyalgia impairment showed the greatest improvement, suggesting this approach benefits those most affected.
Area of Science:
- Rheumatology
- Pain Management
- Rehabilitation Medicine
Background:
- Fibromyalgia is a chronic condition characterized by widespread pain and fatigue.
- Effective and accessible treatment options for fibromyalgia are needed.
Purpose of the Study:
- To assess the efficacy of a brief, intensive fibromyalgia treatment program.
- To identify patient characteristics predicting a positive treatment response.
Main Methods:
- A 1.5-day interdisciplinary program was implemented.
- Fibromyalgia Impact Questionnaire (FIQ) and Multidimensional Pain Inventory (MPI) were used for pre- and post-treatment assessments.
- 100 patients participated, with 74 completing follow-up.
Main Results:
- Significant improvements were observed in FIQ total score (P<.001), MPI pain severity (P<.001), and MPI interference (P=.01).
- High pretreatment FIQ scores, indicating greater impairment, were strongly associated with better treatment outcomes (P<.001).
Conclusions:
- A brief, interdisciplinary fibromyalgia program can effectively reduce symptoms.
- Patients with more severe fibromyalgia may experience the most benefit.
- Findings can inform the development of convenient and effective fibromyalgia treatments.
More Related Videos
08:33A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
13:18Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
Published on: April 10, 2026